SCHD's Stunning Reversal: Schwab's Flagship Dividend ETF Is Up 29% and Climbing

Schwab U.S. Dividend Equity ETF (SCHD) has returned 29.29% year to date in 2026, roughly 18 percentage points ahead of the S&P 500's approximately 11% gain. The article attributes the outperformance to a rotation from expensive AI and megacap technology stocks toward lower-volatility dividend payers amid geopolitical uncertainty and tariffs. SCHD also benefited from limited exposure to struggling megacap tech and a March index refresh that added large dividend names including UnitedHealth, Procter & Gamble, and Accenture.

Analysis

The relevant mechanism is not the dividend yield itself but factor-flow concentration: sustained allocations into quality/value ETFs mechanically support the largest liquid constituents and can temporarily decouple their multiples from company-specific earnings revisions. That favors PG, ABT and AMGN as lower-beta beneficiaries, while QCOM and TXN offer more upside if the rotation broadens into cyclical value; their dividend credentials can attract incremental passive demand without requiring a full semiconductor growth rerating.

The risk is that the rotation has already become crowded after a sharp relative move. A renewed decline in real yields or an AI-led earnings upside surprise would likely re-open the valuation gap in favor of megacap growth, reversing the quality-dividend trade quickly. Within the basket, UNH remains exposed to policy and medical-cost trend surprises, COP/CVX remain tied to crude rather than defensive flows, and HD is the weakest “defensive” expression if tariffs or rates suppress housing turnover.

Treat the March constituent-change attribution skeptically: index inclusion is usually a one-off flow event, not a durable earnings catalyst. The next 1-3 month confirmation should be continued ETF creations alongside positive FY earnings revisions for defensives; absent revisions, multiple expansion becomes vulnerable. Over 6-18 months, the more durable opportunity is selective ownership of companies able to maintain dividend growth while preserving buybacks and margins, rather than broad exposure after the factor’s strong run.

Key Decisions for Investors

• Do not chase SCHD outright at current relative strength; wait for a 5-8% pullback or evidence of continued weekly creations and upward 2027 EPS revisions before initiating a tactical position. Exit if SCHD/QQQ relative strength breaks below its 50-day moving average.
• Prefer a 3-6 month quality-dividend pair: long PG and ABT versus short HD, sized beta-neutral. PG/ABT have more resilient demand and pricing power; HD is more exposed to rate-sensitive turnover and input-cost pressure. Reassess on a material fall in mortgage rates or a positive housing-turnover inflection.
• For cyclical participation, accumulate TXN and QCOM only on semiconductor order-data confirmation; use a 6-month horizon and cap downside at a 10% stop. The thesis fails if handset/industrial inventory normalization stalls or managements cut capital-return commitments.
• Maintain COP/CVX as oil exposure rather than as a defensive-dividend proxy. Hedge or reduce if Brent falls below the level that supports current free-cash-flow and buyback assumptions; geopolitical premium can unwind faster than equity-factor flows.